- Intracellular Biologics
  
  Groundbreaking science with the potential to cause a seismic shift in disease treatment.
- Experienced Team
  
  Proven leadership team with the business and scientific acumen to create value.
- Collaborative Approach
  
  Critical alignment with corporate and scientific partners to validate and unlock the value of the Permeon advantage.
- Enabling Platform
  
  Proprietary Intraphilin™ Technology Platform enables existing biologics to function in cells and treat disease.

Inside-The-Cell Therapies.

Outside-The-Box Thinking.

NEWS View all news >>

February 23, 2012Permeon Biologics Announces the Appointment of Katherine S. Bowdish, Ph.D. as President and Chief Scientific Officer More

October 10, 2011Emerging Company Profile- Permeon: Supercharging protein delivery More

September 26, 2011Kudos to Four Little Biotechs Doing Cool Science More